Media Advisory
Effective March 23, 2021, the Center City Vaccination Center (CCVC) in Philadelphia, PA will exclusively administer second doses of the Pfizer-BioNTech Covid-19 vaccine for three weeks. First doses will not be available at the CCVC during this time. Vaccination will be by appointment only for those individuals who have received an initial dose of the vaccine; walk-ups will no longer be permitted.
After these three weeks, the CCVC will begin to administer the Johnson & Johnson single-dose COVID-19 vaccine for two weeks. The specific timing and operational details related to this switch to the Johnson & Johnson vaccine will be announced in the coming weeks.
To register for a COVID-19 vaccine, Philadelphia residents are encouraged to complete the City of Philadelphia's Vaccine Interest Form, if they have not yet done so, at www.phila.gov/vaccineinterest. Eligible residents will be prioritized for an appointment. To check current vaccine eligibility, please visit the Philadelphia Department of Public Health website.
Contact Us
For media inquiries, please contact the FEMA Region 3 News Desk.
Email: femar3newsdesk@fema.dhs.gov
Source: Department of Homeland Security, Federal Emergency Management Agency
